
Fidotek Corp is a Generative AI bioscience company focused on the US pet market, targeting 120 million pets. The company offers a next-generation AI platform that digitally transforms multiple high-margin verticals within the $135 billion pet industry. Key product areas include personalized Web3 retail, pet diagnostics, pet health insurance, advanced telemedicine, and drug development. Fidotek holds multiple US patents, positioning it as a patent leader in the pet industry with no comparable solutions currently available. The company operates under bespoke revenue models and is recognized as a qualified Arizona bioscience business, offering tax incentives to accredited angel investors under Arizona's Angel Investment program.

Fidotek Corp is a Generative AI bioscience company focused on the US pet market, targeting 120 million pets. The company offers a next-generation AI platform that digitally transforms multiple high-margin verticals within the $135 billion pet industry. Key product areas include personalized Web3 retail, pet diagnostics, pet health insurance, advanced telemedicine, and drug development. Fidotek holds multiple US patents, positioning it as a patent leader in the pet industry with no comparable solutions currently available. The company operates under bespoke revenue models and is recognized as a qualified Arizona bioscience business, offering tax incentives to accredited angel investors under Arizona's Angel Investment program.